Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice

To test the hypothesis that myricitrin (MYR) improves type 2 diabetes, we examined the effect of MYR on hyperglycemia, glucose intolerance, hepatic steatosis, and inflammation in high-fat diet (HFD) and streptozotocin (STZ)-induced type 2 diabetic mice. Male C57BL/6J mice were randomly divided into...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Do Yeon, Kim, Sang Ryong, Jung, Un Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084451/
https://www.ncbi.nlm.nih.gov/pubmed/32182914
http://dx.doi.org/10.3390/ijms21051870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084451/
https://www.ncbi.nlm.nih.gov/pubmed/32182914
http://dx.doi.org/10.3390/ijms21051870

Ejemplares similares